Gastroesophageal Reflux Disease (GERD)
Also known as: GERD, Acid Reflux Disease, Chronic Acid Reflux, Heartburn, Acid reflux
GERD is a chronic condition in which stomach acid frequently flows back into the esophagus, irritating its lining. It occurs when the lower esophageal sphincter weakens or relaxes abnormally. Left untreated, GERD can lead to esophagitis, Barrett's esophagus, and an increased risk of esophageal cancer.
Last updated October 31, 2026
Understanding Gastroesophageal Reflux Disease (GERD)
Gastroesophageal reflux disease is what reflux becomes when it is frequent or damaging enough to be a disease in its own right: troublesome symptoms at least twice a week, or visible injury to the esophagus, regardless of how often it burns. It affects about one adult in five in Western countries and is the commonest reason people take acid-suppressing drugs long term. Around 30% of people with GERD have erosive esophagitis on endoscopy; the remaining 70% have non-erosive reflux disease, with a normal-looking lining but abnormal acid exposure or a hypersensitive esophagus. GERD also shows up outside the gullet as chronic cough, hoarseness, throat clearing, worsened asthma and dental erosion, which is why it is often missed when heartburn is absent.
The core defect is a failing barrier at the junction between stomach and esophagus. A hiatal hernia, present in most people with severe GERD, pulls the sphincter away from the diaphragm that normally reinforces it. The sphincter may be weak at rest or relax too often. Once acid is up, slow clearance (poor esophageal contractions, less saliva at night) and delayed stomach emptying prolong the contact. Repeated acid and bile exposure inflames and erodes the lining, graded A to D on the Los Angeles scale. Over years, scarring can narrow the esophagus into a stricture, and in 10 to 15% of people with long-standing GERD the lining transforms into intestinal-type tissue called Barrett's esophagus, which carries a small risk of adenocarcinoma, about 0.1 to 0.3% per year, and is monitored by surveillance endoscopy.
GERD is chronic and relapsing: most people who stop treatment see symptoms return within months. Proton pump inhibitors are the cornerstone, healing erosive esophagitis in 80 to 90% of people after eight weeks and maintaining healing when continued. For non-erosive disease, guidelines favor the lowest effective dose or on-demand use, and stepping down to an H2 blocker when possible. Potassium-competitive acid blockers such as vonoprazan suppress acid faster and more completely for severe esophagitis. Long-term PPI use has been linked in observational studies to fractures, C. difficile infection, pneumonia, low B12 and magnesium, kidney disease and dementia, but a three-year randomized trial of 17,598 people found only a slight rise in gut infections, so most of those associations are probably not causal. Surgery (fundoplication) or a magnetic sphincter device (LINX) suits people with proven reflux who cannot or will not take drugs; in refractory, pH-proven GERD, surgery succeeded in 67% versus 28% for intensified medication in a 2019 trial.
Natural approaches in GERD are adjuncts, not replacements, and nothing has strong evidence. Melatonin has the best data: in small controlled trials it eased symptoms alone and sped relief when added to omeprazole, probably by raising sphincter pressure. Deglycyrrhizinated licorice strengthens the protective mucus layer and improved dyspepsia in one trial, ginger accelerates gastric emptying, and the mucilage herbs slippery elm and marshmallow root are soothing but untested. Apple cider vinegar and betaine HCl have no trials and rest on a low-acid theory that pH studies contradict. Where natural measures genuinely earn their place is as support during a supervised step-down from a PPI, in mild non-erosive disease, and alongside the lifestyle changes that have the only large-scale evidence. Anyone with erosive esophagitis, a stricture or Barrett's should not swap a PPI for herbs; the drug is doing a job that can be seen on endoscopy.
The mistake at both extremes is the same: treating the PPI as either harmless or poisonous. Many people stay on a double dose for years without a single review, when a large share could step down or stop. Others stop abruptly after reading about side effects, hit the rebound acid surge that follows weeks of suppression (seen in 44% of healthy volunteers after an eight-week course), conclude they are dependent, and restart. The right path is a planned taper with a doctor, with alginate or an H2 blocker as a bridge, and an endoscopy first if there is any doubt about what the drug has been protecting.
At a Glance
- Common symptoms
- Burning sensation in the chest (heartburn), especially after eating, Regurgitation of food or sour liquid, Difficulty swallowing (dysphagia)
- Main treatments
- Lifestyle modifications (weight loss, elevating head of bed, dietary changes), Proton pump inhibitors (omeprazole, esomeprazole, lansoprazole), H2 receptor blockers (famotidine) for milder symptoms
- Category
- Digestive · Affects approximately 20% of the U.S. adult population
- See a doctor if
- Heartburn occurs more than twice a week
Symptoms
Causes
- Weakened or dysfunctional lower esophageal sphincter
- Hiatal hernia allowing acid to reflux more easily
- Delayed stomach emptying (gastroparesis)
- Obesity increasing abdominal pressure
- Pregnancy-related hormonal and physical changes
Risk Factors
- Obesity or overweight
- Pregnancy
- Hiatal hernia
- Smoking
- Eating large meals or eating late at night
- Certain foods (fatty, spicy, chocolate, caffeine, alcohol)
Diagnosis
- Clinical diagnosis based on symptoms and response to acid-suppressing therapy
- Upper endoscopy to evaluate for esophagitis or Barrett's esophagus
- Ambulatory 24-hour pH monitoring
- Esophageal manometry to assess sphincter function
Treatment
- Lifestyle modifications (weight loss, elevating head of bed, dietary changes)
- Proton pump inhibitors (omeprazole, esomeprazole, lansoprazole)
- H2 receptor blockers (famotidine) for milder symptoms
- Antacids for occasional symptom relief
- Fundoplication surgery or LINX device for refractory cases
Natural remedies for gastroesophageal reflux disease (gerd): what the evidence says
Ranked by the strength of human evidence for gastroesophageal reflux disease (gerd) specifically. These sit alongside medical care, not in place of it.
Melatonin
Moderate evidenceIn a controlled trial of 36 GERD patients, 3 mg of melatonin nightly for eight weeks improved heartburn and raised lower esophageal sphincter pressure; adding it to omeprazole 20 mg brought faster relief than omeprazole alone. A 351-patient open comparison reported better symptom regression with a 6 mg melatonin-based combination than with omeprazole at 40 days, but the product had six other ingredients and no blinding.
- Studied dose
- 3 to 6 mg at bedtime for 8 weeks, usually alongside a PPI or during a PPI taper.
- Cautions
- Sedating; avoid alcohol and other sedatives. Fluvoxamine raises melatonin levels several-fold. Possible interactions with warfarin, nifedipine, immunosuppressants and diabetes medicines. Limited safety data in pregnancy.
Deglycyrrhizinated licorice (DGL)
Preliminary evidenceLicorice flavonoids boost mucus and prostaglandin production in the upper gut lining, relevant because mucosal defense, not just acid volume, determines injury in GERD. In a 50-patient, 30-day placebo-controlled trial of a 75 mg glycyrrhizin-free extract twice daily for functional dyspepsia, symptom scores improved significantly more than placebo. No placebo-controlled GERD trial exists.
- Studied dose
- DGL 380 to 400 mg chewed 20 minutes before meals up to 3 times daily, or a glycyrrhizin-free extract 75 mg twice daily, for 4 weeks.
- Cautions
- Use only deglycyrrhizinated forms. Whole licorice raises blood pressure, drops potassium, and interacts with diuretics, digoxin, corticosteroids and antihypertensives; avoid in pregnancy, heart failure and kidney disease. Monitor blood pressure even on DGL if hypertensive.
Ginger
Preliminary evidenceAbout a third of people with GERD empty their stomach slowly, prolonging the post-meal reflux window. Ginger 1.2 g sped gastric half-emptying from 16 to 12 minutes in an 11-patient crossover study and accelerated emptying in 24 healthy volunteers. Its anti-nausea effect is well documented in pregnancy and chemotherapy trials, but no trial has measured esophageal acid exposure or heartburn directly.
- Studied dose
- 1 to 1.5 g dried ginger or standardized extract before the main meal, or fresh ginger tea; not above 4 g a day.
- Cautions
- Antiplatelet; caution with warfarin, DOACs and clopidogrel, and stop 1 to 2 weeks before surgery. Safe up to 1 g a day in pregnancy. Excess ginger causes heartburn, so stop if symptoms worsen.
Slippery elm
Preliminary evidenceA demulcent whose mucilage forms a protective gel over inflamed mucosa, mechanistically appealing for the raw esophagus and throat of GERD and laryngopharyngeal reflux. Clinical trial data in reflux are nonexistent; the evidence is laboratory work on mucosal coating and a small IBS trial of a combination product. It is low-risk and inexpensive, which is the honest case for it.
- Studied dose
- 2 to 4 g powder in warm water or 400 to 500 mg capsules, up to 3 times daily, after meals and at bedtime.
- Cautions
- Take other medicines, including PPIs, 2 hours apart, because the gel can slow absorption. Avoid in pregnancy for lack of safety data. Choose sustainably harvested products; the tree is overharvested.
Marshmallow root
Preliminary evidenceMarshmallow polysaccharides form a bioadhesive layer on epithelial cells that laboratory models show reduces irritation and persists through repeated rinsing. Small trials support it for dry cough and throat irritation, which overlap with the extra-esophageal symptoms of GERD, but there are no reflux-specific trials. Its traditional use for the hoarse, scratchy throat of silent reflux is reasonable but unproven.
- Studied dose
- 2 to 5 g dried root as a cold infusion (steep 1 to 2 hours), up to 3 times daily, or 400 to 800 mg capsules.
- Cautions
- Separate from oral drugs by 2 hours. May lower blood sugar slightly; monitor with insulin or sulfonylureas. Not enough data in pregnancy or breastfeeding.
Apple cider vinegar
Preliminary evidenceThere is no clinical trial of apple cider vinegar in GERD, erosive esophagitis or heartburn, and the low-acid hypothesis behind it is contradicted by pH monitoring, which shows normal acid output in the wrong place. In erosive disease the risk is concrete: acetic acid on an already inflamed lining can deepen injury, and undiluted vinegar has caused esophageal burns. Included to say clearly that it is not an evidence-based option.
- Studied dose
- No evidence-based dose for GERD. Never undiluted.
- Cautions
- Can worsen esophagitis, erode enamel and irritate ulcers. Chronic high intake has lowered potassium, with interactions with diuretics, digoxin and insulin. Especially inappropriate with Barrett's esophagus or a stricture.
Betaine HCl
Preliminary evidenceMarketed to raise stomach acid for people who believe their reflux is due to too little acid. The only human study gave 1,500 mg to healthy volunteers whose acid had been drug-suppressed and showed a brief drop in gastric pH. No study has tested it in GERD, and in a condition defined by acid damage the logic runs backward. It has no role in erosive esophagitis or Barrett's esophagus.
- Studied dose
- No studied dose in GERD. If used under supervision for documented achlorhydria, 650 to 1,500 mg with protein meals.
- Cautions
- Contraindicated with ulcers, gastritis, esophagitis, and with NSAIDs, aspirin or corticosteroids. Redundant if you take a PPI, H2 blocker or vonoprazan. Not studied in pregnancy.
What matters day to day
- Adopt all five anti-reflux habits at once: healthy weight, never smoking, 30 minutes of daily activity, no more than two cups of coffee, tea or soda a day, and a prudent diet. Together they were associated with 37% fewer GERD symptoms in 43,000 women, and still helped people already on PPIs.
- Lose weight if overweight: in a structured program where participants lost an average of 13 kg, GERD prevalence fell from 37% to 15%, and each 3.5-point BMI drop roughly halves symptom risk.
- Stop eating 3 hours before bed, raise the bed head 6 to 8 inches, and sleep on your left side; together these cut nighttime acid exposure, the kind most linked to esophagitis and Barrett's.
- Stop smoking: it loosens the sphincter, reduces saliva and slows healing of esophagitis, and quitting improved severe reflux in normal-weight people in a large Norwegian cohort.
- Review your medicines with a pharmacist: NSAIDs, calcium channel blockers, nitrates, some antidepressants, bisphosphonates and anticholinergics all worsen reflux or injure the esophagus.
Prevention
- Maintain a healthy weight
- Avoid eating within 3 hours of bedtime
- Elevate the head of your bed 6–8 inches
- Avoid trigger foods and beverages
- Quit smoking
When to See a Doctor
- Heartburn occurs more than twice a week
- Symptoms persist despite over-the-counter medications
- You experience difficulty swallowing or unintentional weight loss
- You develop chest pain (rule out cardiac causes first)
Frequently Asked Questions
References
- Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology (2022)
- Moayyedi P, Eikelboom JW, Bosch J, et al.. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Pantoprazole. Gastroenterology (2019)
- Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology (2022)
- Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology (2009)
- Spechler SJ, Hunter JG, Jones KM, et al.. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. New England Journal of Medicine (2019)
- Kandil TS, Mousa AA, El-Gendy AA, Abbas AM. The potential therapeutic effect of melatonin in gastro-esophageal reflux disease. BMC Gastroenterology (2010)
- Mehta RS, Nguyen LH, Ma W, Staller K, Song M, Chan AT. Association of Diet and Lifestyle With the Risk of Gastroesophageal Reflux Disease Symptoms in US Women. JAMA Internal Medicine (2021)
- Raveendra KR, Jayachandra, Srinivasa V, et al.. An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study. Evidence-Based Complementary and Alternative Medicine (2012)
- Singh M, Lee J, Gupta N, et al.. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (2013)
- Shaheen NJ, Falk GW, Iyer PG, et al.. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. American Journal of Gastroenterology (2022)
Related Conditions
Evidence-graded guides
Lab tests that relate to gastroesophageal reflux disease (gerd)
Related from the Supplement Library
Slippery Elm
PreliminaryHerb · GI tract soothing and protection
Licorice Root (DGL)
ModerateHerb · Gut lining support and mucosal healing (DGL)
Ginger
StrongHerb · Anti-nausea (motion, pregnancy, chemotherapy)
Probiotics (Lactobacillus)
StrongProbiotic · Gut microbiome balance and diversity
Melatonin
StrongCompound · Regulates circadian rhythm and sleep-wake cycle
These supplements have been studied in relation to Gastroesophageal Reflux Disease (GERD). Always consult your healthcare provider before starting any supplement, especially if you take medications.
Related Reading
Have questions about Gastroesophageal Reflux Disease (GERD)?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.